Fig. 7From: Hepatitis B virus suppresses complement C9 synthesis by limiting the availability of transcription factor USF-1 and inhibits formation of membrane attack complex: implications in disease pathogenesisRecovery of serum C9 level and reduction in viral/bacterial/endotoxin load in CHB patients after Tenofovir-therapy. Levels of a HBV-DNA, b alanine aminotransferase (ALT), c C9, d bacterial-DNA and e endotoxin in sera of CHB patients at baseline and after 12 months of Tenofovir therapy. Wilcoxon matched paired t tests were performed. *p < 0.05, **p < 0.005Back to article page